Yıl: 2021 Cilt: 2 Sayı: 1 Sayfa Aralığı: 27 - 35 Metin Dili: İngilizce DOI: 10.51271/jpea-2021-0110 İndeks Tarihi: 28-11-2022

Rare Autoinflammatory Diseases: A Single Center Experience of 47 Patients

Öz:
Autoinflammatory diseases include a group disease characterized by recurrent systemic inflammatory attacks due to failure in the regulation of the innate immune system. The beginning time of autoinflammatory disease are the most commonly in childhood. Autoinflammatory disease which having different clinical forms are rare, therefore diagnosis is often delayed. To determine the clinical, laboratory and radiological characteristics of children with rare autoinflammatory diseases and in which patients to consider autoinflammatory disease. Forty seven patients diagnosed with rare autoinflammatory diseases between 2010 and 2020 were analyzed retrospectively. Demographic characteristics, clinical courses, laboratory and imaging findings of the patients were recorded. Forty-seven with rare autoinflammatory patients evaluated. Twenty-three patients had Chronic Nonbacterial Osteomyelitis (CNO), seven patients had Mevalonate Kinase Deficiency (MKD), six patients had Blau Syndrome / Early-Onset Sarcoidosis (BS/EOS) Syndrome, three patients had Cryopyrin-associated periodic fever syndrome (CAPS), three patients had Autoinflammatory Vasculitis, one patient had Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD) syndrome, one patient had Neonatal Onset Pancytopenia, Autoinflammation, Rash and Episodic HLH (NOARCH) syndrome. Three of our patients were being followed up with a diagnosis of undiferantiated systemic autoinflammatory disease (uSAID).Autoinflammatory diseases may have different presentations. Steril and recurrent inflammation should be warning clinicians.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Galon J, Aksentijevich I, McDermott MF, O'Shea JJ, Kastner DL. TNFRSF1A mutations and autoinflammatory syndromes. Curr Opin Immunol. 2000;12:479-486. [CrossRef]
  • 2. McDermott MF, Aksentijevich I, Galon J, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell. 1999;97:133-144. [CrossRef]
  • 3. Georgin-Lavialle S, Ducharme-Benard S, Sarrabay G, Savey L, Grateau G, Hentgen V. Systemic autoinflammatory diseases: Clinical state of the art. Best Pract Res Clin Rheumatol. 2020;34:101529. [CrossRef]
  • 4. Marino A, Tirelli F, Giani T, Cimaz R. Periodic fever syndromes and the autoinflammatory diseases (AIDs). J Transl Autoimmun. 2019;3:100031. [CrossRef]
  • 5. Çiçek SÖ, Şahin N, Karaman ZF, et al. The Possible Relationship Between Familial Mediterranean Fever and Chronic Nonbacterial Osteomyelitis: Coincidence or Coexistence? J Clin Rheumatol. 2020;10.1097/RHU.0000000000001431. [CrossRef]
  • 6. PaÇ Kisaarslan A, SÖzerİ B, Şahİn N, et al. Blau Syndrome and Early-Onset Sarcoidosis: A Six Case Series and Review of the Literature. Arch Rheumatol. 2019;35:117-127. [CrossRef]
  • 7. Giedion A, Holthusen W, Masel LF, Vischer D. [Subacute and chronic "symmetrical" osteomyelitis]. Ann Radiol (Paris). 1972;15:329-342.
  • 8. Morbach H, Hedrich CM, Beer M, Girschick HJ. Autoinflammatory bone disorders. Clin Immunol. 2013;147:185-196. [CrossRef]
  • 9. MajeedHA,KalaawiM,MohantyD,etal.Congenitaldyserythropoietic anemia and chronic recurrent multifocal osteomyelitis in three related children and the association with Sweet syndrome in two siblings. J Pediatr. 1989;115:730-734. [CrossRef]
  • 10. Aksentijevich I, Masters SL, Ferguson PJ, et al.An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med 2009; 360:2426-2437. [CrossRef]
  • 11. Lindor NM, Arsenault TM, Solomon H, Seidman CE, McEvoy MT. A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc. 1997;72:611-615. [CrossRef]
  • 12. Smith EJ, Allantaz F, Bennett L, et al. Clinical, Molecular, and Genetic Characteristics of PAPA Syndrome: A Review. Curr Genomics. 2010;11:519-527. [CrossRef]
  • 13. Jansson A, Renner ED, Ramser J, et al. Classification of non- bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology (Oxford). 2007;46:154-160. [CrossRef]
  • 14. Girschick H, Finetti M, Orlando F, et al. The multifaceted presentation of chronic recurrent multifocal osteomyelitis: a series of 486 cases from the Eurofever international registry. Rheumatology (Oxford). 2018;57:1203-1211. [CrossRef]
  • 15. Kısaarslan AP, Sözeri B, Gündüz Z, Zararsız G, Poyrazoğlu H, Düşünsel R. Evaluation of factors affecting the duration of disease-modifying anti-rheumatic drugs application in patients with enthesitis-related arthritis. Eur J Rheumatol. 2019;6:130-135. [CrossRef]
  • 16. Demirkaya E, Ozen S, Bilginer Y, et al. The distribution of juvenile idiopathic arthritis in the eastern Mediterranean: results from the registry of the Turkish Paediatric Rheumatology Association. Clin Exp Rheumatol. 2011;29:111-116. [CrossRef]
  • 17. Kaiser D, Bolt I, Hofer M, et al. Chronic nonbacterial osteomyelitis in children: a retrospective multicenter study. Pediatr Rheumatol Online J. 2015;13:25. [CrossRef]
  • 18. Beck C, Morbach H, Beer M, et al. Chronic nonbacterial osteomyelitis in childhood: prospective follow-up during the first year of anti-inflammatory treatment. Arthritis Res Ther. 2010;12:R74. [CrossRef]
  • 19. Prasad C, Salvadori MI, Rupar CA. Severe phenotypic spectrum of mevalonate kinase deficiency with minimal mevalonic aciduria. Mol Genet Metab. 2012;107:756-759. [CrossRef]
  • 20. Pepper RJ, Lachmann HJ. Autoinflammatory Syndromes in Children. Indian J Pediatr. 2016;83:242-247. [CrossRef]
  • 21. Figueras-Nart I, Mascaró JM Jr, Solanich X, Hernández-Rodríguez J. Dermatologic and Dermatopathologic Features of Monogenic Autoinflammatory Diseases. Front Immunol. 2019;10:2448. [CrossRef]
  • 22. Drenth JP, Cuisset L, Grateau G, et al. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nat Genet. 1999;22:178-181. [CrossRef]
  • 23. Caso F, Rigante D, Vitale A, et al. Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues. Int J Rheumatol. 2013;2013:513782. [CrossRef]
  • 24. Simon A, van der Meer JW. Pathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes. Am J Physiol Regul Integr Comp Physiol. 2007;292:R86-R98. [CrossRef]
  • 25. Jeyaratnam J, Frenkel J. Management of Mevalonate Kinase Deficiency: A Pediatric Perspective. Front Immunol. 2020;11:1150. [CrossRef]
  • 26. Yel S, Gunduz Z, Bastug F, et al. Amyloidosis in a child with hyperimmunoglobulinemia D syndrome. Iran J Kidney Dis. 2013;7:70-72. [CrossRef]
  • 27. Dursun I, Sözeri B, Paç Kısaarslan A, et al. Canakinumab is safe in the treatment of renal transplant patient having amyloidosis secondary to hyper. Ig-D syndrome; Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part one: Genoa, Italy. 28 September–01 October 2016. Pediatr Rheumatol Online J. 2017;15:37. [CrossRef]
  • 28. Blau EB. Familial granulomatous arthritis, iritis, and rash. J Pediatr. 1985;107:689-693. [CrossRef]
  • 29. Becker ML, Rose CD. Blau syndrome and related genetic disorders causing childhood arthritis. Curr Rheumatol Rep. 2005;7:427-433. [CrossRef]
  • 30. Milman N, Ursin K, Rødevand E, Nielsen FC, Hansen TV. A novel mutation in the NOD2 gene associated with Blau syndrome: a Norwegian family with four affected members. Scand J Rheumatol. 2009;38:190-197. [CrossRef]
  • 31. Sfriso P, Caso F, Tognon S, Galozzi P, Gava A, Punzi L. Blau syndrome, clinical and genetic aspects. Autoimmun Rev. 2012;12:44-51. [CrossRef]
  • 32. Alonso D, Elgart GW, Schachner LA. Blau syndrome: a new kindred. J Am Acad Dermatol. 2003;49:299-302. [CrossRef]
  • 33. Wouters CH, Maes A, Foley KP, Bertin J, Rose CD. Blau syndrome, the prototypic auto-inflammatory granulomatous disease. Pediatr Rheumatol Online J. 2014;12:33. [CrossRef]
  • 34. Rosé CD, Pans S, Casteels I, et al. Blau syndrome: cross- sectional data from a multicentre study of clinical, radiological and functional outcomes. Rheumatology (Oxford). 2015;54:1008- 1016. [CrossRef]
  • 35. Rosé CD, Aróstegui JI, Martin TM, et al. NOD2-associated pediatric granulomatous arthritis, an expanding phenotype: study of an international registry and a national cohort in Spain. Arthritis Rheum. 2009;60:1797-1803. [CrossRef]
  • 36. Galozzi P, Negm O, Greco E, et al. Ex vivo and in vitro production of pro-inflammatory cytokines in Blau syndrome. Reumatismo. 2015;66:277-284. [CrossRef]
  • 37. Ebrahimiadib N, Samra KA, Domina AM, et al. A Novel NOD2- associated Mutation and Variant Blau Syndrome: Phenotype and Molecular Analysis. Ocul Immunol Inflamm. 2018;26:57-64. [CrossRef]
  • 38. Saulsbury FT, Wouters CH, Martin TM, et al. Incomplete penetrance of the NOD2 E383K substitution among members of a pediatric granulomatous arthritis pedigree. Arthritis Rheum. 2009;60:1804- 1806. [CrossRef]
  • 39. Ozen S. What's new in autoinflammation?. Pediatr Nephrol. 2019;34:2449-2456. [CrossRef]
  • 40. Navallas M, Inarejos Clemente EJ, Iglesias E, Rebollo-Polo M, Zaki FM, Navarro OM. Autoinflammatory diseases in childhood, part 1: monogenic syndromes. Pediatr Radiol. 2020;50:415-430. [CrossRef]
  • 41. Federici S, Vanoni F, Ben-Chetrit E, et al. An International Delphi Survey for the Definition of New Classification Criteria for Familial Mediterranean Fever, Mevalonate Kinase Deficiency, TNF Receptor-associated Periodic Fever Syndromes, and Cryopyrin- associated Periodic Syndrome. J Rheumatol. 2019;46:429-436. [CrossRef]
  • 42. Hashkes PJ, Toker O. Autoinflammatory syndromes. Pediatr Clin North Am. 2012;59:447-470. [CrossRef]
  • 43. Del Porto F, Cifani N, Proietta M, et al. NLRP12 gene mutations and auto-inflammatory diseases: ever-changing evidence. Rheumatology (Oxford). 2020;59:3129-3136. [CrossRef]
  • 44. Mehr S, Allen R, Boros C, et al. Cryopyrin-associated periodic syndrome in Australian children and adults: Epidemiological, clinical and treatment characteristics. J Paediatr Child Health. 2016;52:889- 895. [CrossRef]
  • 45. Levy R, Gérard L, Kuemmerle-Deschner J, et al. Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry. Ann Rheum Dis. 2015;74:2043-2049. [CrossRef]
  • 46. Caorsi R, Lepore L, Zulian F, et al. The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age. Arthritis Res Ther. 2013;15:R33. [CrossRef]
  • 47. Posch C, Kaulfersch W, Rappersberger K. Cryopyrin-associated periodic syndrome. Pediatr Dermatol. 2014;31:228-231. [CrossRef]
  • 48. Keddie S, Parker T, Lachmann HJ, Ginsberg L. Cryopyrin- Associated Periodic Fever Syndrome and the Nervous System. Curr Treat Options Neurol. 2018;20:43. [CrossRef]
  • 49. Peleg H, Ben-Chetrit E. Vasculitis in the autoinflammatory diseases. Curr Opin Rheumatol. 2017;29:4-11. [CrossRef]
  • 50. Ginsberg S, Rosner I, Rozenbaum M, et al. Autoinflammatory associated vasculitis. Semin Arthritis Rheum. 2016;46:367-371. [CrossRef]
  • 51. Abbara S, Grateau G, Ducharme-Bénard S, Saadoun D, Georgin- Lavialle S. Association of Vasculitis and Familial Mediterranean Fever. Front Immunol. 2019;10:763. [CrossRef]
  • 52. Demir S, Sag E, Dedeoglu F, Ozen S. Vasculitis in Systemic Autoinflammatory Diseases. Front Pediatr. 2018;6:377. [CrossRef]
  • 53. Pathak S, McDermott MF, Savic S. Autoinflammatory diseases: update on classification diagnosis and management. J Clin Pathol. 2017;70:1-8. [CrossRef]
  • 54. Giulino L, Guinan EC, Gillio AP, Drachtman RA, Teruya-Feldstein J, Boulad F. Sweet syndrome in patients with Fanconi anaemia: association with extracutaneous manifestations and progression of haematological disease. Br J Haematol. 2011;154:278-281. [CrossRef]
  • 55. Webber L, Cummins M, Mann R, Shaw L, Ghinai R, Mahon C. Panniculitis in a 3-year-old child with Fanconi anemia-associated bone marrow hypoplasia heralds transformation to acute myeloid leukemia. Pediatr Dermatol. 2019;36:725-727. [CrossRef]
  • 56. Liwak-Muir U, Mamady H, Naas T, et al. Impaired activity of CCA- adding enzyme TRNT1 impacts OXPHOS complexes and cellular respiration in SIFD patient-derived fibroblasts. Orphanet J Rare Dis. 2016;11:79. [CrossRef]
  • 57. Yang L, Xue X, Zeng T, et al. Novel biallelic TRNT1 mutations lead to atypical SIFD and multiple immune defects. Genes Dis. 2020;7:128-137. [CrossRef]
  • 58. Papa R, Rusmini M, Volpi S, et al. Next generation sequencing panel in undifferentiated autoinflammatory diseases identifies patients with colchicine-responder recurrent fevers. Rheumatology (Oxford). 2020;59:344-360. [CrossRef]
  • 59. Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytic lymphohistiocytosis. Blood. 2011;118:4041- 4052. [CrossRef]
  • 60. Rosado FG, Kim AS. Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis. Am J Clin Pathol. 2013;139:713-727. [CrossRef]
  • 61. Lawson CD, Ridley AJ. Rho GTPase signaling complexes in cell migration and invasion. J Cell Biol. 2018;217:447-457. [CrossRef]
  • 62. Lam MT, Coppola S, Krumbach OHF, et al. A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function. J Exp Med. 2019;216:2778-2799. [CrossRef]
  • 63. Ter Haar NM, Eijkelboom C, Cantarini L, et al. Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases. Ann Rheum Dis. 2019;78:1405-1411. [CrossRef]
  • 64. Hwa V. STAT5B deficiency: Impacts on human growth and immunity. Growth Horm IGF Res. 2016;28:16-20. [CrossRef]
  • 65. Takeuchi O, Kawai T, Sanjo H, et al. TLR6: A novel member of an expanding toll-like receptor family. Gene. 1999;231:59-65. [CrossRef]
  • 66. Feldmann J, Callebaut I, Raposo G, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell. 2003;115:461- 473. [CrossRef]
  • 67. Yu CH, Moecking J, Geyer M, Masters SL. Mechanisms of NLRP1- Mediated Autoinflammatory Disease in Humans and Mice. J Mol Biol. 2018;430:142-152. [CrossRef]
  • 68. Sahin N,Özdemir S,Berdelı A. et al. M1184V mutation in NLRP1: is that polymorphism or pathogenic mutation? 10th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID). Pediatr Rheumatol. 2019;17-18. [CrossRef]
APA TAŞKIN S, Pac Kisaarslan A, DOGANTAN S, Poyrazoğlu M, Özdemir Çiçek S, Sahin N, Dusunsel R (2021). Rare Autoinflammatory Diseases: A Single Center Experience of 47 Patients. , 27 - 35. 10.51271/jpea-2021-0110
Chicago TAŞKIN Sema Nur,Pac Kisaarslan Aysenur,DOGANTAN SEYDA,Poyrazoğlu Muammer Hakan,Özdemir Çiçek Sümeyra,Sahin Nihal,Dusunsel Ruhan Rare Autoinflammatory Diseases: A Single Center Experience of 47 Patients. (2021): 27 - 35. 10.51271/jpea-2021-0110
MLA TAŞKIN Sema Nur,Pac Kisaarslan Aysenur,DOGANTAN SEYDA,Poyrazoğlu Muammer Hakan,Özdemir Çiçek Sümeyra,Sahin Nihal,Dusunsel Ruhan Rare Autoinflammatory Diseases: A Single Center Experience of 47 Patients. , 2021, ss.27 - 35. 10.51271/jpea-2021-0110
AMA TAŞKIN S,Pac Kisaarslan A,DOGANTAN S,Poyrazoğlu M,Özdemir Çiçek S,Sahin N,Dusunsel R Rare Autoinflammatory Diseases: A Single Center Experience of 47 Patients. . 2021; 27 - 35. 10.51271/jpea-2021-0110
Vancouver TAŞKIN S,Pac Kisaarslan A,DOGANTAN S,Poyrazoğlu M,Özdemir Çiçek S,Sahin N,Dusunsel R Rare Autoinflammatory Diseases: A Single Center Experience of 47 Patients. . 2021; 27 - 35. 10.51271/jpea-2021-0110
IEEE TAŞKIN S,Pac Kisaarslan A,DOGANTAN S,Poyrazoğlu M,Özdemir Çiçek S,Sahin N,Dusunsel R "Rare Autoinflammatory Diseases: A Single Center Experience of 47 Patients." , ss.27 - 35, 2021. 10.51271/jpea-2021-0110
ISNAD TAŞKIN, Sema Nur vd. "Rare Autoinflammatory Diseases: A Single Center Experience of 47 Patients". (2021), 27-35. https://doi.org/10.51271/jpea-2021-0110
APA TAŞKIN S, Pac Kisaarslan A, DOGANTAN S, Poyrazoğlu M, Özdemir Çiçek S, Sahin N, Dusunsel R (2021). Rare Autoinflammatory Diseases: A Single Center Experience of 47 Patients. The journal of pediatric academy (Online), 2(1), 27 - 35. 10.51271/jpea-2021-0110
Chicago TAŞKIN Sema Nur,Pac Kisaarslan Aysenur,DOGANTAN SEYDA,Poyrazoğlu Muammer Hakan,Özdemir Çiçek Sümeyra,Sahin Nihal,Dusunsel Ruhan Rare Autoinflammatory Diseases: A Single Center Experience of 47 Patients. The journal of pediatric academy (Online) 2, no.1 (2021): 27 - 35. 10.51271/jpea-2021-0110
MLA TAŞKIN Sema Nur,Pac Kisaarslan Aysenur,DOGANTAN SEYDA,Poyrazoğlu Muammer Hakan,Özdemir Çiçek Sümeyra,Sahin Nihal,Dusunsel Ruhan Rare Autoinflammatory Diseases: A Single Center Experience of 47 Patients. The journal of pediatric academy (Online), vol.2, no.1, 2021, ss.27 - 35. 10.51271/jpea-2021-0110
AMA TAŞKIN S,Pac Kisaarslan A,DOGANTAN S,Poyrazoğlu M,Özdemir Çiçek S,Sahin N,Dusunsel R Rare Autoinflammatory Diseases: A Single Center Experience of 47 Patients. The journal of pediatric academy (Online). 2021; 2(1): 27 - 35. 10.51271/jpea-2021-0110
Vancouver TAŞKIN S,Pac Kisaarslan A,DOGANTAN S,Poyrazoğlu M,Özdemir Çiçek S,Sahin N,Dusunsel R Rare Autoinflammatory Diseases: A Single Center Experience of 47 Patients. The journal of pediatric academy (Online). 2021; 2(1): 27 - 35. 10.51271/jpea-2021-0110
IEEE TAŞKIN S,Pac Kisaarslan A,DOGANTAN S,Poyrazoğlu M,Özdemir Çiçek S,Sahin N,Dusunsel R "Rare Autoinflammatory Diseases: A Single Center Experience of 47 Patients." The journal of pediatric academy (Online), 2, ss.27 - 35, 2021. 10.51271/jpea-2021-0110
ISNAD TAŞKIN, Sema Nur vd. "Rare Autoinflammatory Diseases: A Single Center Experience of 47 Patients". The journal of pediatric academy (Online) 2/1 (2021), 27-35. https://doi.org/10.51271/jpea-2021-0110